VEKLURY J Code: J0248
Injection, remdesivir, 1 mg
Q4 2026 Medicare Payment Limit for J0248, effective October 1, 2026: $7.511 per HCPCS billing unit, unchanged from Q3 2026. From CMS's final file.
Drug & Product Overview
About VEKLURY
Veklury is a medication aligned to the HCPCS J Code: J0248 for billing, pricing, and reimbursement purposes in the United States. Classified under COVID-19, it is administered via the intravenous route and manufactured by Gilead Sciences, Inc.
According to CMS Drug Use Information: Remdesivir is used to treat coronavirus disease, also known as COVID-19, for certain patients who are in the hospital. Remdesivir is an antiviral drug. Remdesivir may also be used to treat patients with COVID-19 who are not in the hospital, but have a high risk for COVID-19 complications due to older age, obesity, or ongoing medical conditions (such as lung, kidney, or heart disease, diabetes).
Disclaimer: This is a summary and does not contain all possible information about this product. For complete information about this product or your specific health needs, ask your healthcare professional.
NDC Code Information
Based on publicly available CMS files. The list of NDCs below is not exhaustive.
| NDC Code | Drug | Manufacturer | Billing Units / Pkg | Package Size |
|---|---|---|---|---|
| 61958-2901-02 | Veklury | Gilead Sciences, Inc. | 100 | 100 MG |
VEKLURY Pricing & Reimbursement
National median reimbursement across major commercial payers.
Create an account on PayerPrice for more information →Historical Graphing and Billing Calculator
Log in to calculate billing and reimbursement with live ASP, WAC & AWP pricing.
Login to use the calculator →VEKLURY CPT Administration Codes
The below list of CPT codes is intended for informational purposes only and may not be exhaustive. CPT® codes and descriptions are copyright American Medical Association (AMA). All rights reserved.
| CPT Code | Description |
|---|---|
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis (specify substance or drug); initial, up to 1 hour |
| 96366 | Intravenous infusion, for therapy, prophylaxis, or diagnosis (specify substance or drug); each additional hour (List separately in addition to code for primary procedure) |
CMS does not include Veklury (J0248) on its list of HCPCS pertaining to single-dose containers. Per CMS guidelines, the JZ/JW wastage modifiers may not apply when billing J0248. Wastage billing guide →
VEKLURY Medically Unlikely Edits (MUE)
The most billing units of J0248 Medicare will pay for one patient in one day, as published by CMS. 1 unit = 1 mg.
MAI 3 · Date of Service Edit: Clinical. Per-day limit based on clinical expectations; excess units are denied but may be appealed with documentation of medical necessity. See all MUE limits →
VEKLURY Clinical Information
Indications and drug classification.
This list of indications is not exhaustive and may be subject to errors. The information on BuyandBill.com is intended for informational purposes only and should not be used for medical advice.
Login for BuyandBill.com Analytics
Unlock deeper insights with BuyandBill’s Comparative Report!
- Compare ASP, WAC, and AWP across drugs.
- Visualize Drug Price Movement Over Time
- Tailor reports to drug class, manufacturer, or HCPCS Code.
- Compare Biosimilar and 505(b)(2) products.
Frequently Asked Questions
Is there an available Veklury billing and coding guide?
Are there any available Veklury patient assistance programs?
Where can I find Veklury prescribing information?
Where can I find Veklury side effect information?
Does billing VEKLURY require JZ/JW wastage modifiers?
About BuyandBill.com:
The BuyandBill.com team is dedicated to delivering high-quality coding and billing information for office-administered drugs. We continuously research HCPCS-coded medications to expand our resources and ensure data accuracy. Manufacturers: click here to sponsor your medication, and we will ensure the most accurate and detailed information is displayed.
Related Drug Codes
Explore billing, coding, and pricing for drugs related to VEKLURY.